Postconditioning attenuates no-reflow in STEMI patients. - Wikidata - awgldk - TriplyDB

Postconditioning attenuates no-reflow in STEMI patients.

Postconditioning attenuates no-reflow in STEMI patients.

http://www.wikidata.org/entity/Q46051532

about

Ischaemic postconditioning: cardiac protection after the event Cardioprotection by combined intrahospital remote ischaemic perconditioning and postconditioning in ST-elevation myocardial infarction: the randomized LIPSIA CONDITIONING trial.Cardiovascular remodelling in coronary artery disease and heart failure.Cyclosporine A reduces microvascular obstruction and preserves left ventricular function deterioration following myocardial ischemia and reperfusion.Mechanical post-conditioning in STEMI patients undergoing primary percutaneous coronary intervention.Short-and long-term effects of ischemic postconditioning in STEMI patients: a meta-analysis.Ischemic postconditioning improves the expression of cellular membrane connexin 43 and attenuates the reperfusion injury in rat acute myocardial infarction.Vagal nerve stimulation started just prior to reperfusion limits infarct size and no-reflow Impact of multiple balloon inflations during primary percutaneous coronary intervention on infarct size and long-term clinical outcomes in ST-segment elevation myocardial infarction: real-world postconditioning.In vivo MRI and ex vivo histological assessment of the cardioprotection induced by ischemic preconditioning, postconditioning and remote conditioning in a closed-chest porcine model of reperfused acute myocardial infarction: importance of microvascu Postconditioning in ST-elevation myocardial infarction: a systematic review, critical appraisal, and meta-analysis of randomized clinical trials.The Role of NMDA Receptors in the Development of Brain Resistance through Pre- and Postconditioning.Ischemic Postconditioning After Routine Thrombus Aspiration During Primary Percutaneous Coronary Intervention: Rationale and Design of the POstconditioning Rotterdam Trial.Treatment of Myocardial Ischemia/Reperfusion Injury by Ischemic and Pharmacological Postconditioning.The challenges and impact of microvascular injury in ST-elevation myocardial infarction.The pathophysiology of acute myocardial infarction and strategies of protection beyond reperfusion: a continual challenge.Ischemic postconditioning: mechanisms, comorbidities, and clinical application.Revisiting myocardial necrosis biomarkers: assessment of the effect of conditioning therapies on infarct size by kinetic modelling.Distinct cardioprotective mechanisms of immediate, early and delayed ischaemic postconditioning.Early kinetics of serum Interleukine-17A and infarct size in patients with reperfused acute ST-elevated myocardial infarction.Ischaemic conditioning: intervening to protect; before, after, and at a distance.Ischemic postconditioning during primary percutaneous coronary intervention.No post-conditioning in the human heart with thrombolysis in myocardial infarction flow 2-3 on admission.

P2860

Q26853129-306E5EC0-134E-40AE-A401-807CA9FC2DDB Q34494832-3F4E16AB-359D-423F-A5C9-AC2D6598998D Q35090566-2BDC1A26-A944-4CA9-BE53-C6E7F47BB0BC Q35126767-753CB19A-CD66-49E2-8632-2AF27B19EFB7 Q35783843-CB51BA9A-22A1-4CE3-BACA-87CEE08D5DC2 Q35843019-F5A7FC92-55BB-47F1-B6C7-101AA273AEC9 Q35948946-CA9110B1-5A53-428C-8B65-130CB35F79A3 Q35995878-4A17E56E-A4A5-45C8-A7BF-4AE5760DD342 Q37633996-233A8521-20AE-48F8-85EE-FDFF4275FDF3 Q37733638-C43B5FAE-D83F-4CEC-812A-9D7FD097E79B Q38241835-4CE8A4EC-1AFD-4E24-9FA3-45EF2AB065AE Q38285669-26F6001A-EDBD-4104-987C-2CAC0AC22C42 Q38386304-48D1F624-C247-434B-9218-1DDFF62B90BC Q38542449-0DA50236-C541-44E2-A62F-DB17CF5DEA4B Q38705817-93EEE43C-22C8-4A0A-A8E7-ECEA4D2B298D Q38880162-DBA7C927-5223-461C-921B-A4806BBE2E2F Q39232678-0C0C4C8E-83EC-479E-B3DF-9B19927A89D9 Q41632039-EC428AA9-9C16-484F-852E-401098FE8E77 Q41755944-8561C52C-39B5-4AC7-899D-909A48144821 Q45797174-B84CEDAD-8F38-4D8C-B4F1-B48DBDA214EF Q47737067-0A5A3140-F455-42BD-AA27-42B01A9395D6 Q48122921-FF3A81F4-A005-4B2E-8332-FD31F2515D24 Q51106338-E2E67649-3455-4FF7-849C-A2331791CA28

P2860

Postconditioning attenuates no-reflow in STEMI patients.

http://www.wikidata.org/entity/Q46051532

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh

2013年學術文章

@zh-hant

name

Postconditioning attenuates no-reflow in STEMI patients.

@en

Postconditioning attenuates no-reflow in STEMI patients.

@nl

type

label

Postconditioning attenuates no-reflow in STEMI patients.

@en

Postconditioning attenuates no-reflow in STEMI patients.

@nl

prefLabel

Postconditioning attenuates no-reflow in STEMI patients.

@en

Postconditioning attenuates no-reflow in STEMI patients.

@nl

P1433

Q46051532-E4ECCA63-02BE-4ED1-BE6E-180AA10297E9

P1476

Q46051532-8D90C674-FA16-46BE-8F85-02EE57CF8974

P2093

Q46051532-0BA9B6EA-E30D-43B2-96CA-F8A481C20DFF

Q46051532-0BB18BC5-21DD-4CEA-BB56-2193151DA169

Q46051532-117E6C38-4D32-44A3-BB3D-DE6C30F5E5DF

Q46051532-264E0C21-0E84-4458-907D-CA6A1EFA2389

Q46051532-36779D3E-9E0A-4808-875E-FBD0561A068C

Q46051532-38AC0F3A-10AE-419F-AD8F-BE07DA5C423E

Q46051532-5FE16DAF-476B-4C50-8D66-EE03A3735FB8

Q46051532-760F656E-94D6-4A86-8F98-0FF5C16AC43C

Q46051532-8D374227-B838-4F57-BD2F-ADA9D8EA91AF

Q46051532-9FFFC478-EAEB-46C2-914F-2874C41B5B2A

P2860

Q46051532-124EE283-303E-4300-8E66-BF80A78A8626

Q46051532-1C16DAA9-858B-4863-9C90-F523F3A6B629

Q46051532-26F4F4EB-D20F-4736-B93F-ED9DA4F7814A

Q46051532-2F9528FD-9C5C-4705-8101-FCF1DCC18B99

Q46051532-32B8B582-B8F6-43C9-AD50-32057ECA7E82

Q46051532-406BA22C-946D-498E-B945-5D1CB7456334

Q46051532-48CE3B97-87D1-4B4B-9AE1-16FCFE93D316

Q46051532-5046C56E-1B5A-4DCD-B06F-D0C409C16863

Q46051532-51642B06-29CE-413F-ADEA-12F9A717F0DF

Q46051532-57AF7AB3-555E-4609-B25A-E9F2E29DC68D

P2888

Q46051532-EF50EF35-4356-47D7-A186-9FC6109D369E

P304

Q46051532-D5512BBF-2BBD-4184-AFC6-E28C29B0DFBF

P31

Q46051532-EC2D1966-F41E-4F10-9AE5-1E1B1DDC332A

P356

Q46051532-25D4520E-27D7-4EEA-BACF-96A2E20CFFE4

P433

Q46051532-5939CB05-8898-4213-98BC-5F8F931FAE88

P478

Q46051532-C5EA04AC-9AB7-44CE-8572-13C6EAF4887F

P50

Q46051532-6F4CEDE1-0D5B-429A-8665-838647C5DFDF

Q46051532-8EE8D48B-2A9E-4D9E-8C57-80AE4CCB20E7

Q46051532-C4859043-C4A9-47DF-9995-17F4ABEFBC85

Q46051532-ECB451E5-BDE5-4DAA-96CE-1AC2686B2E62

P577

Q46051532-1B7250D0-6A70-42C4-92CD-09556C1AA5FE

P5875

Q46051532-47A849CA-ACCF-4CC7-99F6-7C2C0CE91774

P698

Q46051532-74CDA78B-FAEA-4A1E-BEC0-D6274C3131E1

P356

S00395-013-0383-8

P1433

Basic Research in Cardiology

P1476

Postconditioning attenuates no-reflow in STEMI patients.

@en

P2093

Catherine Sportouch

http://www.w3.org/2001/XMLSchema#string

Cyrille Bergerot

http://www.w3.org/2001/XMLSchema#string

Didier Revel

http://www.w3.org/2001/XMLSchema#string

Eric Bonnefoy-Cudraz

http://www.w3.org/2001/XMLSchema#string

François Roubille

http://www.w3.org/2001/XMLSchema#string

Gilles Rioufol

http://www.w3.org/2001/XMLSchema#string

Gérard Finet

http://www.w3.org/2001/XMLSchema#string

Hélène Thibault

http://www.w3.org/2001/XMLSchema#string

Inesse Sahraoui

http://www.w3.org/2001/XMLSchema#string

Ingrid Sanchez

http://www.w3.org/2001/XMLSchema#string

P2860

ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC)

Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning

The "no-reflow" phenomenon after temporary coronary occlusion in the dog.

Association of changes in clinical characteristics and management with improvement in survival among patients with ST-elevation myocardial infarction.

Thrombus aspiration during primary percutaneous coronary intervention is associated with reduced myocardial edema, hemorrhage, microvascular obstruction and left ventricular remodeling

Assessment of no-reflow regions using cardiac MRI.

Coronary microembolization: from bedside to bench and back to bedside.

Coronary no reflow.

The coronary circulation in cardioprotection: more than just one confounder.

Cardioprotection: chances and challenges of its translation to the clinic.

P2888

s00395-013-0383-8

P304

383

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00395-013-0383-8

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

108

http://www.w3.org/2001/XMLSchema#string

P50

Pierre Croisille

Denis Angoulvant

Christophe Piot

P577

2013-09-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

256490415

http://www.w3.org/2001/XMLSchema#string

P698

24022373

http://www.w3.org/2001/XMLSchema#string